Summary
- Current Price
- As of today, NAMS price is $22.49, up +2.55% on
- Current Price All-Time High
- NAMS price is currently -46.71% below its historical high of $42.21 set on
- Market Cap
- NAMS current market cap is $3B, down -10.61% year-over-year
- Revenue
- NAMS current annual revenue is $22.50M, down -50.61% year-over-year
- Next Earnings
- The next earnings release for NAMS is on
Profile
| Metric | Value |
|---|---|
| Full Name | NewAmsterdam Pharma Company N.V. |
| Ticker | NASDAQ: NAMS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Netherlands |
| IPO | |
| Indexes | Not included |
| Website | newamsterdampharma.com |
| Employees | 77 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $22.49 | |
| Price, 1D Change | +2.55% | |
| $3B | ||
| - | ||
| - | ||
| 1.16 | ||
| $22.50M | ||
| Revenue, 1Y Change | -50.61% | |
| -$1.72 | ||
| EPS, 1Y Change | +32.78% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.72 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $22.50M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $22.49 | |
| Price Target | $51.38 | - |
| Price Tgt. Change | +128.48% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$2.15 | - | |
| - | -$2.56 | - | |
| - | -$1.72 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $14.09M | - | |
| - | $45.56M | - | |
| - | $22.50M | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $22.49 | |
| $31.79 | ||
| $27.40 | ||
| $29.88 | ||
| $26.76 | ||
| -$1.69 | ||
| 1.16 | ||
| $1.39 | ||
| 36.59 | ||
| 74.26% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $22.50M | ||
| -$1.72 | ||
| $22.28M | ||
| 99.02% | ||
| -$225.68M | ||
| -1,002.90% | ||
| -$203.82M | ||
| -905.74% | ||
| -$225.46M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 7.88 | ||
| 7.88 | ||
| - | ||
| 2 | ||
| 17.38 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 377.53 | ||
| 4.26 | ||
| -8.41 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $683.43M | ||
| $637.56M | ||
| $769.28M | ||
| $675.70M | ||
| $85.85M | ||
| $85.79M | ||
| $202.00K | ||
| $136.00K | ||
| $8.97M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $226.32M | ||
| $247.97M | ||
| $220.00K | ||
| $0.00 | ||
| $220.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$147.78M | ||
| -$174.92M | ||
| $29.52M | ||
| $246.00K | ||
| -$148.03M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| Guggenheim | → | |
| Needham | → | |
| RBC Capital | → | |
| Stifel | → | |
| Goldman Sachs | → | |
| RBC Capital | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
No data
Screeners with NAMS
FAQ
- What is the ticker symbol for NewAmsterdam Pharma Company N.V.?
- The ticker symbol for NewAmsterdam Pharma Company N.V. is NASDAQ:NAMS
- Does NewAmsterdam Pharma Company N.V. pay dividends?
- No, NewAmsterdam Pharma Company N.V. does not pay dividends
- What sector is NewAmsterdam Pharma Company N.V. in?
- NewAmsterdam Pharma Company N.V. is in the Healthcare sector
- What industry is NewAmsterdam Pharma Company N.V. in?
- NewAmsterdam Pharma Company N.V. is in the Biotechnology industry
- What country is NewAmsterdam Pharma Company N.V. based in?
- NewAmsterdam Pharma Company N.V. is headquartered in Netherlands
- When did NewAmsterdam Pharma Company N.V. go public?
- NewAmsterdam Pharma Company N.V. initial public offering (IPO) was on February 9, 2021
- Is NewAmsterdam Pharma Company N.V. in the S&P 500?
- No, NewAmsterdam Pharma Company N.V. is not included in the S&P 500 index
- Is NewAmsterdam Pharma Company N.V. in the NASDAQ 100?
- No, NewAmsterdam Pharma Company N.V. is not included in the NASDAQ 100 index
- Is NewAmsterdam Pharma Company N.V. in the Dow Jones?
- No, NewAmsterdam Pharma Company N.V. is not included in the Dow Jones index
- When was NewAmsterdam Pharma Company N.V. last earnings report?
- NewAmsterdam Pharma Company N.V.'s most recent earnings report was on August 5, 2026
- When does NewAmsterdam Pharma Company N.V. report earnings?
- The next expected earnings date for NewAmsterdam Pharma Company N.V. is November 4, 2026
Data Sources & References
- NAMS Official Website www.newamsterdampharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1936258/000119312526056029/0001193125-26-056029-index.htm
- NAMS Profile on Yahoo Finance finance.yahoo.com/quote/NAMS
- NAMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nams